Cover Image
市場調查報告書

全球成藥市場預測:主要企業預測

Global OTC Pharmaceutical Market Forecast 2017-2027: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others

出版商 Visiongain Ltd 商品編碼 320889
出版日期 內容資訊 英文 177 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球成藥市場預測:主要企業預測 Global OTC Pharmaceutical Market Forecast 2017-2027: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others
出版日期: 2017年08月15日 內容資訊: 英文 177 Pages
簡介

全球成藥市場預計2016年達到1,270億美元。

本報告提供全球成藥市場相關調查,產業的成長趨勢,各國趨勢,收益預測,以及主要企業的簡介等彙整。

第1章 報告概要

第2章 成藥的簡介

  • 所謂成藥
  • 成藥的分類
  • 所謂對成藥的必要條件
  • OTC交換器
  • 成藥的製造與流通
  • 成藥相關法規
  • 市場區隔

第3章 全球成藥市場預測

  • 全球成藥市場實際成果
  • 全球成藥市場銷售額預測
  • 成藥市場區隔

第4章 主要國家市場預測

  • 各地區明細
  • 各地區預測
  • 市場佔有率的變化:中國的崛起
  • 美國市場
  • 日本市場
  • 市場EU5個國家
  • 中國市場
  • 巴西市場
  • 俄羅斯市場
  • 印度市場
  • 墨西哥市場
  • 其他

第5章 主要企業

  • 主要製造商
  • GSK (跟Novartis的合資)
  • Novartis (跟GSK的OTC合資)
  • Bayer
  • Merck & Co(Bayer收購消費者照護部門)
  • Johnson and Johnson
  • Perrigo
  • Pfizer
  • Procter & Gamble
  • Reckitt Benckiser
  • Sanofi
  • Boehringer Ingelheim
  • Mylan,進入OTC市場

第6章 OTC交換器與未來的成藥

  • 所謂OTC交換器
  • OTC交換器活動
  • 潛在的候補
  • 咳嗽、感冒、過敏
  • 止痛藥
  • 腸胃藥
  • 皮膚
  • 失禁用抗膽鹼藥
  • 口服避孕藥
  • 膽固醇抑制劑的高度需求
  • 其他

第7章 成藥市場定性分析

第8章 結論

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0224

The Global OTC Pharmaceutical market is expected to grow at a CAGR of 6.5% in the first half of the forecast period. The Global OTC Pharmaceutical market is estimated at $127bn in 2016 and is dominated by the cough, cold and allergy segment which holds 23% share of the Global OTC Pharmaceutical market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 177-page report you will receive 82 tables and 79 figures - all unavailable elsewhere.

The 177-page report provides clear detailed insight into the Global OTC Pharmaceutical market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global OTC Pharmaceutical Market forecasts from 2017-2027
  • This report breaks down the revenue forecast of the Global OTC Pharmaceutical market into these leading segments:
  • Analgesics
  • Cough, cold and allergy products
  • Dermatological products
  • Gastrointestinal products
  • Eye Care
  • Smoking Cessation Aids
  • Other products

Each submarket is further divided by region: North America, South America, Europe, Asia-Pacific and RoW

  • This report provides individual revenue forecasts to 2027 for these regional and national markets:
  • North America: the US, Canada, Mexico
  • South America: Brazil, Argentina, Paraguay, Bolivia, Rest of South America
  • Europe: Germany, France, the UK, Spain, Italy, Rest of Europe
  • Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
  • Rest of the World: Middle East, Africa, Other Countries

image1

  • Our study provides a SWOT analysis and Porter's Five Forces analysis of the Global OTC Pharmaceutical market
  • This report discusses the leading companies in the Global OTC Pharmaceutical market
  • Bayer AG
  • GlaxoSmithKline (GSK) Consumer Care
  • Perrigo Company PLC
  • Johnson & Johnson
  • Daiichi Sankyo Co., Ltd
  • Pfizer Inc.
  • Procter & Gamble
  • Sanofi S.A
  • Reckitt Benckiser Group PLC
  • Cipla, Inc.

Visiongain's study is intended for anyone requiring commercial analyses for the Global OTC Pharmaceutical Market. You find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 The OTC Pharmaceuticals Market Overview
  • 1.2 Research Methodology
  • 1.3 Global OTC Pharmaceutical Market Segmentation
  • 1.4 Why You Should Read This Report
  • 1.5 How this report delivers?
  • 1.6 Key Questions Answered by This Analytical Report
  • 1.7 Frequently Asked Questions (FAQ)
  • 1.8 Who is This Report For?
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2. Introduction to OTC Pharmaceuticals

  • 2.1 What Are OTC Pharmaceuticals?
  • 2.2 Classification of OTC Pharmaceuticals
  • 2.3 What are the Requirements for an OTC Pharmaceutical Drug?
  • 2.4 OTC Switching
    • 2.4.1 How Is a Drug Switched from Prescription to OTC?
  • 2.5 Manufacturing and Distribution of OTC Pharmaceuticals
  • 2.6 Regulation of OTC Pharmaceuticals
    • 2.6.1 Regulation of OTC Pharmaceuticals in the US
    • 2.6.2 Regulation of OTC Pharmaceuticals in Japan: Deregulating the Sales of OTCs
    • 2.6.3 Regulation of OTC Pharmaceuticals in Europe
    • 2.6.4 Regulation of OTC Pharmaceuticals in China
    • 2.6.5 Regulation of OTC Pharmaceuticals in Others Countries

3. Global OTC Pharmaceutical Market Forecast 2017-2027

  • 3.1 The Current State of the OTC Pharmaceutical Market

4. Global OTC Pharmaceutical Market by Product: Market Forecast 2017- 2027

  • 4.1 Overview
  • 4.2 Cough, Cold and Allergy
    • 4.2.1 Anti-Allergy Products
  • 4.3 Analgesics
    • 4.3.1 Internal Analgesics
    • 4.3.2 External Analgesics
  • 4.4 Gastrointestinal
  • 4.5 Dermatological
    • 4.5.1 Minor Cuts and Wounds
    • 4.5.2 Acne
    • 4.5.3 Rashes, Itchy Skin, and Dermatitis/Eczema
    • 4.5.4 Cold Sores
    • 4.5.5 Warts
    • 4.5.6 Fungal Skin Infections
    • 4.5.7 Haemorrhoids
    • 4.5.8 Other Dermatological Products
  • 4.6 Eye Care
    • 4.6.1 Dry Eye Syndrome
    • 4.6.2 Bacterial Conjunctivitis
    • 4.6.3 Ocular Allergy and Allergic Conjunctivitis
    • 4.6.4 Treatment of Ocular Allergy/ Allergic Conjunctivitis
  • 4.7 Smoking Cessation Aids
  • 4.8 Other Products

5. Global OTC Pharmaceutical Market by National Market: Market Forecast 2017- 2027

  • 5.1 Global OTC Pharmaceuticals Market: Regional Forecast, 2017-2027
  • 5.2 North American OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.2.1 USA OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.2.2 Canada OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.2.3 Mexico OTC Pharmaceutical Market Forecasts 2017-2027
  • 5.3 South American OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.3.1 Brazil OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.3.2 Argentina OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.3.3 Paraguay OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.3.4 Bolivia OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.3.5 Rest of South America OTC Pharmaceutical Market Forecasts 2017-2027
  • 5.4 European OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.4.1 France OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.4.2 Germany OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.4.3 UK OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.4.4 Spain OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.4.5 Italy OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.4.6 Rest of Europe OTC Pharmaceutical Market Forecasts 2017-2027
  • 5.5 Asia-Pacific OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.5.1 China OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.5.2 Japan OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.5.3 India OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.5.4 Australia OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.5.5 Thailand OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.5.6 Rest of Asia-Pacific OTC Pharmaceutical Market Forecasts 2017-2027
  • 5.6 Rest of World OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.6.1 Middle East OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.6.2 Africa OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.6.3 Other Countries OTC Pharmaceutical Market Forecasts 2017-2027

6. Qualitative Analysis of the OTC Pharmaceutical Market, 2017-2027

  • 6.1 SWOT Analysis of the OTC Pharmaceutical Market
  • 6.2 Strengths
    • 6.2.1 Healthcare Systems, Third Party Payers, and Manufacturers: All have Incentives to Push for OTC Drug Consumption
      • 6.2.1.1 Manufacturers Can Reap OTC Sales Benefits
      • 6.2.1.2 Third Party Payers: Reducing the Cost Burden
      • 6.2.1.3 Healthcare Systems: Pushing the Cost to the Consumer
    • 6.2.2 Many Pharmaceutical Companies Have a Strong Potential OTC Portfolio
    • 6.2.3 Regulators Are Encouraging OTC Approvals
    • 6.2.4 Effective Distribution Networks Due to Expansion of Retail Pharmacy and Alternative Distributors
    • 6.2.5 Deterring the Consumption of Counterfeit Drugs
    • 6.2.6 Cultural Changes Will Support Self-Medication with OTC Medicines
  • 6.3 Weaknesses
    • 6.3.1 Pharma Companies Remain Focused on Prescription Drugs
    • 6.3.2 Manufacturing Problems Affects Sales and Reputation of OTC Drugs
    • 6.3.3 OTC Products are Vulnerable to Price Controls by Governments
    • 6.3.4 Downward Cost Pressures of OTC Drugs
  • 6.4 Opportunities
    • 6.4.1 Demographic and Economic Changes Will Create Growth Opportunities
    • 6.4.2 New OTC Switch Categories
    • 6.4.3 Strong Growth in Emerging Markets
    • 6.4.4 New Healthcare Technologies May enable OTC Approvals
    • 6.4.5 Opportunities to Drive Sales via Social Media and Online Marketing
    • 6.4.6 Self-Medication Can Reduce the Under Treatment of Disease
  • 6.5 Threats
    • 6.5.1 Competition from Private-Label Brands Will Reduce Profitability
    • 6.5.2 Regulatory Concerns Over Safety and Misuse may Lead to Withdrawal of Products
    • 6.5.3 Resistance to OTC Switching from Some Groups in Certain Countries
  • 6.6 Porter's Five Forces Analysis of the OTC Pharmaceutical Market
    • 6.6.1 Rivalry Among Competitors [High]
    • 6.6.2 Threat of New Entrants [Medium]
    • 6.6.3 Power of Suppliers [Low]
    • 6.6.4 Power of Buyers [Medium]
    • 6.6.5 Threats of Substitutes [Medium]

7. Leading Companies in the OTC Pharmaceutical Market

  • 7.1 Bayer AG
    • 7.1.1 Bayer AG: Company Overview
    • 7.1.2 Bayer AG: Product Portfolio
    • 7.1.3 Bayer AG: Recent Developments
  • 7.2 GlaxoSmithKline PLC (GSK Consumer Care)
    • 7.2.1 GlaxoSmithKline PLC: Company Overview
    • 7.2.2 GlaxoSmithKline PLC: Product Portfolio
    • 7.2.3 GlaxoSmithKline PLC: Recent Developments
  • 7.3 Johnson & Johnson
    • 7.3.1 Johnson & Johnson: Company Overview
    • 7.3.2 Johnson & Johnson: Product Portfolio
    • 7.3.3 Johnson & Johnson: Recent Developments
  • 7.4 Perrigo Company PLC
    • 7.4.1 Perrigo Company PLC: Company Overview
    • 7.4.2 Perrigo Company PLC: Product Portfolio
    • 7.4.3 Perrigo Company PLC: Recent Developments
  • 7.5 Daiichi Sankyo Co., Ltd.
    • 7.5.1 Daiichi Sankyo Co., Ltd.: Company Overview
    • 7.5.2 Daiichi Sankyo Co., Ltd.: Recent Developments
  • 7.6 Pfizer Inc.
    • 7.6.1 Pfizer Inc.: Company Overview
    • 7.6.2 Pfizer Inc.: Product Portfolio
    • 7.6.3 Pfizer Inc.: Recent Developments
  • 7.7 Procter & Gamble
    • 7.7.1 Procter & Gamble: Company Overview
    • 7.7.2 Procter & Gamble: Product Portfolio
    • 7.7.3 Procter & Gamble: Recent Developments
  • 7.8 Sanofi S.A.
    • 7.8.1 Sanofi S.A.: Company Overview
    • 7.8.2 Sanofi S.A.: Product Portfolio
    • 7.8.3 Sanofi S.A: Recent Developments
  • 7.9 Reckitt Benckiser Group PLC
    • 7.9.1 Reckitt Benckiser Group PLC: Company Overview
    • 7.9.2 Reckitt Benckiser Group PLC: Product Portfolio
    • 7.9.3 Reckitt Benckiser Group PLC: Recent Developments
  • 7.10 Cipla Inc.
    • 7.10.1 Cipla Inc.: Company Overview
    • 7.10.2 Cipla Inc.: Product Portfolio
    • 7.10.3 Cipla Inc.: Recent Developments

8. Conclusions

  • 8.1 The World OTC Pharmaceutical Market in 2016-2017
    • 8.1.1 The Leading OTC Product Categories
    • 8.1.2 Leading National Markets: Emerging Market Represent a Large Proportion
    • 8.1.3 The Global OTC Market Growth Factors
    • 8.1.4 Potential OTC Switching, 2017-2027
    • 8.1.5 Emerging OTC Markets
  • 8.2 Concluding Remarks

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Tables

  • Table 3.1 Global OTC Pharmaceutical Market Forecast ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.1 Global OTC Pharmaceutical Market Forecast, by Product ($bn, AGR%) 2017-2027
  • Table 4.2 OTC Cough, Cold and Allergy Active Ingredients, 2017
  • Table 4.3 Global OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.4 OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, by Geography, ($bn, AGR%) 2017-2027
  • Table 4.5 OTC Internal Analgesic Active Ingredients, 2017
  • Table 4.6 OTC External Analgesic Active Ingredients, 2017
  • Table 4.7 Global OTC Pharmaceutical Market for Analgesics Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.8 OTC Pharmaceutical Market for Analgesics Market Forecast, by Geography ($bn, AGR%) 2017-2027
  • Table 4.9 Global OTC Pharmaceutical Market for Gastrointestinal Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.10 OTC Pharmaceutical Market for Gastrointestinal Market Forecast, by Geography ($bn, AGR%) 2017-2027
  • Table 4.11 OTC Antifungal Active Ingredients, 2017
  • Table 4.12 Global OTC Pharmaceutical Market for Dermatological Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.13 OTC Pharmaceutical Market for Dermatological Market Forecast, by Geography, ($bn, AGR%) 2017-2027
  • Table 4.14 OTC Dry Eye Syndrome Active Ingredients, 2017
  • Table 4.15 OTC Bacterial Conjunctivitis Active Ingredients, 2017
  • Table 4.16 OTC Ocular Allergy Active Ingredients, 2017
  • Table 4.17 Global OTC Pharmaceutical Market for Eye Care Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.18 OTC Pharmaceutical Market for Eye Care Market Forecast, by Geography ($bn, AGR%) 2017-2027
  • Table 4.19 OTC Smoking Cessation Aid Active Ingredients, 2017
  • Table 4.20 Global OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.21 OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, by Geography ($bn, AGR%) 2017-2027
  • Table 4.22 Global OTC Pharmaceutical Market for Other Products Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.23 OTC Pharmaceutical Market for Other Products Market Forecast,by Geography ($bn, AGR%) 2017-2027
  • Table 5.1 OTC Pharmaceutical Market Forecast, by Geography ($bn, AGR%) 2017-2027
  • Table 5.2 North America OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
  • Table 5.3 USA OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.4 Canada OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.5 Mexico OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.6 South America OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
  • Table 5.7 Brazil OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.8 Argentina OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.9 Paraguay OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.10 Bolivia OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.11 Rest of South America OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.12 European OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
  • Table 5.13 France OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.14 Germany OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.15 UK OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.16 Spain OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.17 Italy OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.18 Rest of European OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.19 Asia-Pacific OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
  • Table 5.20 China OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.21 Selected Leading Companies in the Japanese OTC Pharma Market, 2017
  • Table 5.22 Japan OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.23 India OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.24 Australia OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.25 Thailand OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.26 Rest of Asia-Pacific OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.27 Rest of World OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
  • Table 5.28 Middle East OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.29 Africa OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.30 Other Countries OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 7.1 Bayer AG: Company Overview
  • Table 7.2 Bayer AG: Product Portfolio
  • Table 7.4 GlaxoSmithKline PLC: Company Overview
  • Table 7.5 GlaxoSmithKline PLC: Product Portfolio
  • Table 7.6 GlaxoSmithKline PLC: Recent Developments
  • Table 7.7 Johnson & Johnson: Company Overview
  • Table 7.8 Johnson & Johnson: Product Portfolio
  • Table 7.9 Johnson & Johnson: Recent Developments
  • Table 7.10 Perrigo Company PLC: Company Overview
  • Table 7.11 Perrigo Company PLC: Product Portfolio
  • Table 7.12 Perrigo Company PLC: Recent Developments
  • Table7.13 Daiichi Sankyo Co., Ltd.: Company Overview
  • Table 7.14 Daiichi Sankyo Co., Ltd.: Recent Developments
  • Table 7.15 Pfizer Inc.: Company Overview
  • Table 7.16 Pfizer Inc.: Product Portfolio
  • Table 7.17 Pfizer Inc.: Recent Developments
  • Table 7.18 Procter & Gamble: Company Overview
  • Table 7.19 Procter & Gamble: Product Portfolio
  • Table 7.20 Procter & Gamble: Recent Developments
  • Table 7.21 Sanofi S.A.: Company Overview
  • Table 7.22 Sanofi S.A.: Product Portfolio
  • Table 7.23 Sanofi S.A: Recent Developments
  • Table 7.24 Reckitt Benckiser Group PLC: Company Overview
  • Table 7.25 Reckitt Benckiser Group PLC: Product Portfolio
  • Table 7.26 Reckitt Benckiser Group PLC: Recent Developments
  • Table 7.27 Cipla Inc.: Company Overview
  • Table 7.28 Cipla Inc.: Product Portfolio
  • Table 7.29 Cipla Inc.: Recent Developments

List of Figures

  • Figure 1.1 OTC Pharmaceuticals: Overview of Submarkets
  • Figure 2.1 The OTC Pharmaceutical Supply Chain, 2017
  • Figure 3.1 OTC Pharmaceutical Market, by Product, ($bn), 2017-2027
  • Figure 3.2 OTC Pharmaceutical Market, by Geography, ($bn), 2017-2027
  • Figure 4.1 OTC Pharmaceutical Market, by Product, Market Share (%), 2016
  • Figure 4.2 OTC Pharmaceutical Market, by Product, Forecast ($bn) 2017-2027
  • Figure 4.3 OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.4 OTC Pharmaceutical Market for Analgesics Market Forecast, by Geography ($bn) 2017-2027
  • Figure 4.5 OTC Pharmaceutical Market for Gastrointestinal Market Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.6 OTC Pharmaceutical Market for Dermatological Market Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.7 OTC Pharmaceutical Market for Eye Care Market Forecast, by Geography($bn) 2017-2027
  • Figure 4.8 OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.9 OTC Pharmaceutical Market for Other Products Market Forecast, by Geography($bn) 2017-2027
  • Figure 5.1 OTC Pharmaceutical Market Forecast, by Geography ($bn) 2017-2027
  • Figure 5.2 Global OTC Pharmaceutical Market, by Geography, Market Share (%), 2016
  • Figure 5.3 North America OTC Pharmaceutical Market Forecast, by Country ($bn) 2017-2027
  • Figure 5.4 North America OTC Pharmaceutical Market, by Country, Market Share (%), 2016
  • Figure 5.5 USA OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.6 Canada OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.7 Mexico OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.8 South America OTC Pharmaceutical Market Forecast, by Country ($bn) 2017-2027
  • Figure 5.9 South America OTC Pharmaceutical Market, by Country, Market Share (%), 2016
  • Figure 5.10 Brazil OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.11 Argentina OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.12 Paraguay OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.13 Bolivia OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.14 Rest of South America OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.15 Europe OTC Pharmaceutical Market Forecast, by Country($bn) 2017-2027
  • Figure 5.16 Europe OTC Pharmaceutical Market, by Country, Market Share (%), 2016
  • Figure 5.17 France OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.18 Germany OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.19 UK OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.20 Spain OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.21 Italy OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.22 Rest of Europe OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.23 Asia-Pacific OTC Pharmaceutical Market Forecast, by Country ($billion) 2017-2027
  • Figure 5.24 Asia-Pacific OTC Pharmaceutical Market, by Country, Market Share (%), 2016
  • Figure 5.25 China OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.26 Japan OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.27 India OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.28 Australia OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.29 Thailand OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.30 Rest of Asia-Pacific OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.31 RoW OTC Pharmaceutical Market Forecast, by Country ($bn) 2017-2027
  • Figure 5.32 Rest of World OTC Pharmaceutical Market, by Country, Market Share (%), 2016
  • Figure 5.33 Middle East OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.34 Africa OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.35 Other Countries OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 6.1 Porter's Five Analysis of the OTC Pharmaceutical Market, 2017
  • Figure 7.1 Bayer AG, Revenue, ($million), 2012-2016
  • Figure 7.2 Bayer AG, Product Segments Share (%), 2016
  • Figure 7.3 Bayer AG, Geographic Presence Share (%), 2016
  • Figure 7.4 GlaxoSmithKline PLC, Revenue, ($million), 2012-2016
  • Figure 7.5 GlaxoSmithKline PLC, Product Segments Share (%), 2016
  • Figure 7.6 GlaxoSmithKline PLC, Geographical Presence Share (%), 2016
  • Figure 7.7 Johnson & Johnson, Revenue, ($million), 2012-2016
  • Figure 7.8 Johnson & Johnson, Product Segments Share (%), 2016
  • Figure 7.9 Johnson & Johnson, Geographical Presence Share (%), 2016
  • Figure 7.10 Perrigo Company PLC, Revenue, ($million), 2012-2016
  • Figure 7.11 Perrigo Company PLC, Product Segments Share (%), 2016
  • Figure 7.12 Perrigo Company PLC, Geographical Presence Share (%), 2016
  • Figure 7.13 Daiichi Sankyo Co., Ltd., Revenue, ($million), 2012-2016
  • Figure 7.14 Daiichi Sankyo Co., Ltd., Product Segments Share (%), 2016
  • Figure 7.15 Daiichi Sankyo Co., Ltd., Geographical Presence Share (%), 2016
  • Figure 7.16 Pfizer Inc., Revenue, ($million), 2012-2016
  • Figure 7.17 Pfizer Inc., Product Segments Share (%), 2016
  • Figure 7.18 Pfizer Inc., Geographical Presence Share (%), 2016
  • Figure 7.19 Procter & Gamble, Revenue, ($million), 2012-2016
  • Figure 7.20 Procter & Gamble, Product Segments Share (%), 2016
  • Figure 7.21 Procter & Gamble, Geographical Presence Share (%), 2016
  • Figure 7.22 Sanofi S.A., Revenue, ($million), 2012-2016
  • Figure 7.23 Sanofi S.A., Product Segments Share (%), 2016
  • Figure 7.24 Sanofi S.A., Geographical Presence Share (%), 2016
  • Figure 7.25 Reckitt Benckiser Group PLC, Revenue, ($million), 2012-2016
  • Figure 7.26 Reckitt Benckiser Group PLC, Product Segments Share (%), 2016
  • Figure 7.27 Cipla Inc., Revenue, ($million), 2012-2016
  • Figure 7.28 Cipla Inc., Product Segments Share (%), 2016
  • Figure 8.1 Global OTC Pharmaceutical Market Revenue, by Product Type ($bn), 2017-2027
  • Figure 8.2 Global OTC Pharmaceutical Market Revenue, by Geography ($bn), 2017-2027

Companies Listed

  • Abbott Medical Optics
  • Aché Laboratórios Farmacêuticos
  • Actavis
  • Adams Respiratory Therapeutics
  • Akorn
  • Alcon
  • Allergan
  • Alliance Boots
  • Almirall
  • Amerisource Bergen
  • ANVISA
  • Apotex
  • Arena Pharmaceuticals
  • Aspen Pharmacare
  • Astellas Pharma
  • AstraZeneca
  • Aurobindo
  • B.F. Ascher & Company
  • Bausch & Lomb
  • Bayer
  • Boehringer Ingelheim
  • Boots
  • Bristol-Myers Squibb
  • Cardinal Health
  • Celesio
  • China Resources Sanjiu Pharmaceutical
  • Ciba
  • Cilag
  • Cipla
  • Costco
  • CSPC (China Shijiazhuang Pharmaceutical Group)
  • CVS
  • Daiichi Sankyo
  • Dalkhimpharm
  • Dollar General
  • Dr. Reddy's Laboratories
  • Eisai
  • Eli Lilly
  • EMS
  • Eurofarma
  • Fosun Pharma
  • Galderma
  • Genomma Lab
  • GSK
  • Guangzhou Pharmaceutical
  • Harbin Pharmaceutical Group
  • Heritage/Insight
  • Hisamitsu
  • Hypermacas
  • Im Co., Ltd.
  • Insight
  • Ipca Laboratories
  • JB Chemicals
  • Johnson & Johnson
  • Kangmei Pharmaceutical
  • Kowa
  • Kroger
  • Lion
  • LOréal
  • Lupin Limited
  • Mankind Pharma
  • McKesson
  • Mead Johnson
  • Menarini
  • Merck
  • Mylan
  • North China Pharmaceutical
  • Novartis
  • Nycomed
  • Omega Pharma
  • Otsuka
  • Paras Pharmaceuticals
  • Perrigo
  • Pfizer
  • Pharmstandard
  • Phoenix
  • Prestige Brands
  • Procter & Gamble
  • Purdue Pharma
  • Ranbaxy
  • Ratiopharm
  • Reckitt Benckiser
  • Roche
  • Rohto
  • Roxane Labs
  • Sam's Club
  • Sandoz
  • Sanofi
  • Sato
  • Sergeant
  • Shanghai Pharmaceuticals
  • Shionogi
  • Sinopharm
  • SkyePharma
  • Somaxon Pharmaceuticals
  • Sotex
  • SSL International
  • Stada
  • Sun Pharma
  • Taisho
  • Takeda
  • Teva
  • Torrent Pharmaceuticals
  • Typharm
  • UCB Pharma
  • União Química
  • Valeant
  • Velcera
  • Veropharm
  • Vivus

Organizations Mentioned in the Report

  • Association of the European Self-Medication Industry (AESGP)
  • National Pharmaceutical Pricing Authority (NPPA)
  • The Brazilian Health Surveillance Agency
  • The European Medicines Agency (EMA)
  • The Food and Drug Administration (FDA)
  • The General Directorate of Pharmaceuticals and Pharmacy (IEGM) (Turkey)
  • The Medicines and Healthcare products Regulatory Agency (MHRA)
  • The Ministry of Health, Labour and Welfare (MHLW)
  • The Pharmaceutical and Medical Devices Agency (PMDA)
Back to Top